Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest

Takahiro Niimura, Yoshito Zamami, Toshihiro Koyama, Yuki Izawa-Ishizawa, Masashi Miyake, Tadashi Koga, Keisaku Harada, Ayako Ohshima, Toru Imai, Yutaka Kondo, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki, Shiro Hinotsu, Mitsunobu KanoKeisuke Ishizawa

Research output: Contribution to journalArticle

Abstract

There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge.

Original languageEnglish
Article number17919
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Heart Arrest
Hydrocortisone
Survival
Survival Rate
Length of Stay
Out-of-Hospital Cardiac Arrest
Propensity Score
Health Insurance
Odds Ratio
Therapeutics
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • General

Cite this

Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest. / Niimura, Takahiro; Zamami, Yoshito; Koyama, Toshihiro; Izawa-Ishizawa, Yuki; Miyake, Masashi; Koga, Tadashi; Harada, Keisaku; Ohshima, Ayako; Imai, Toru; Kondo, Yutaka; Imanishi, Masaki; Takechi, Kenshi; Fukushima, Keijo; Horinouchi, Yuya; Ikeda, Yasumasa; Fujino, Hiromichi; Tsuchiya, Koichiro; Tamaki, Toshiaki; Hinotsu, Shiro; Kano, Mitsunobu; Ishizawa, Keisuke.

In: Scientific Reports, Vol. 7, No. 1, 17919, 01.12.2017.

Research output: Contribution to journalArticle

Niimura, T, Zamami, Y, Koyama, T, Izawa-Ishizawa, Y, Miyake, M, Koga, T, Harada, K, Ohshima, A, Imai, T, Kondo, Y, Imanishi, M, Takechi, K, Fukushima, K, Horinouchi, Y, Ikeda, Y, Fujino, H, Tsuchiya, K, Tamaki, T, Hinotsu, S, Kano, M & Ishizawa, K 2017, 'Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest', Scientific Reports, vol. 7, no. 1, 17919. https://doi.org/10.1038/s41598-017-17686-3
Niimura, Takahiro ; Zamami, Yoshito ; Koyama, Toshihiro ; Izawa-Ishizawa, Yuki ; Miyake, Masashi ; Koga, Tadashi ; Harada, Keisaku ; Ohshima, Ayako ; Imai, Toru ; Kondo, Yutaka ; Imanishi, Masaki ; Takechi, Kenshi ; Fukushima, Keijo ; Horinouchi, Yuya ; Ikeda, Yasumasa ; Fujino, Hiromichi ; Tsuchiya, Koichiro ; Tamaki, Toshiaki ; Hinotsu, Shiro ; Kano, Mitsunobu ; Ishizawa, Keisuke. / Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{60852b3c20624b58b3fffccd8df52892,
title = "Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest",
abstract = "There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2{\%} of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1{\%}] vs. 240/2172 [11.0{\%}], adjusted odds ratio: 4.2, 95{\%} CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge.",
author = "Takahiro Niimura and Yoshito Zamami and Toshihiro Koyama and Yuki Izawa-Ishizawa and Masashi Miyake and Tadashi Koga and Keisaku Harada and Ayako Ohshima and Toru Imai and Yutaka Kondo and Masaki Imanishi and Kenshi Takechi and Keijo Fukushima and Yuya Horinouchi and Yasumasa Ikeda and Hiromichi Fujino and Koichiro Tsuchiya and Toshiaki Tamaki and Shiro Hinotsu and Mitsunobu Kano and Keisuke Ishizawa",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-17686-3",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest

AU - Niimura, Takahiro

AU - Zamami, Yoshito

AU - Koyama, Toshihiro

AU - Izawa-Ishizawa, Yuki

AU - Miyake, Masashi

AU - Koga, Tadashi

AU - Harada, Keisaku

AU - Ohshima, Ayako

AU - Imai, Toru

AU - Kondo, Yutaka

AU - Imanishi, Masaki

AU - Takechi, Kenshi

AU - Fukushima, Keijo

AU - Horinouchi, Yuya

AU - Ikeda, Yasumasa

AU - Fujino, Hiromichi

AU - Tsuchiya, Koichiro

AU - Tamaki, Toshiaki

AU - Hinotsu, Shiro

AU - Kano, Mitsunobu

AU - Ishizawa, Keisuke

PY - 2017/12/1

Y1 - 2017/12/1

N2 - There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge.

AB - There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge.

UR - http://www.scopus.com/inward/record.url?scp=85038844371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038844371&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-17686-3

DO - 10.1038/s41598-017-17686-3

M3 - Article

C2 - 29263333

AN - SCOPUS:85038844371

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 17919

ER -